Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127245351 | 12724535 | 1 | I | 20160824 | 20160908 | 20160908 | EXP | FR-MLMSERVICE-20160818-0396694-1 | FR-ALKEM LABORATORIES LIMITED-FR-ALKEM-2016-00160 | ALKEM | 60.00 | YR | M | Y | 0.00000 | 20160908 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127245351 | 12724535 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 1 G, BID | 91249 | 1 | G | Q12H | ||||||||
| 127245351 | 12724535 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | 4 MG, QD | 0 | 4 | MG | QD | ||||||||
| 127245351 | 12724535 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | 7.5 MG, QD | 0 | 7.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127245351 | 12724535 | 1 | Immunosuppression |
| 127245351 | 12724535 | 2 | Immunosuppression |
| 127245351 | 12724535 | 3 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127245351 | 12724535 | LT |
| 127245351 | 12724535 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127245351 | 12724535 | Acute kidney injury | |
| 127245351 | 12724535 | Cryptosporidiosis infection | |
| 127245351 | 12724535 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |